Startups
MinervaX

MinervaX

https://minervax.com

Developer of prophylactic vaccine against Group B Streptococcus.

Summary

Seedtable Score
  • 54
Locations
Company Size
  • 1 to 10 employees
Last Stage Round
  • Series C
Industry

Total funding Amount

$220M

Fundraising History

  • Oct 11 '23 Series C
    $57M
  • Dec 15 '22 Series C
    $23M
  • Dec 15 '22 Debt Financing
    $53M
  • Dec 01 '20 Series B
    $58M
  • Jan 01 '19 Unknown
    $5M
  • Jan 08 '14 Seed
    $3.1M

Investors

  • EQT Partners
    Series C
  • OrbiMed
    Series C
  • Pureos Bioventures
    Series C
  • European Investment Bank
    Debt Financing
  • Industrifonden
    Series B
  • Wellington Partners
    Series B
  • Novo A/S
    Seed
  • Sunstone Life Science Ventures
    Seed
  • Vaekstfonden
    Seed